Study of Roxadustat Conversion in Subjects Receiving Stable ESA or as Initial Anemia Treatment in Chronic Dialysis Patients
Condition: Anemia Associated With End Stage Renal Disease (ESRD) Intervention: Drug: Roxadustat Sponsors: FibroGen; AstraZeneca Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials